Findings from the current study demonstrate that over half of chronic HF patients in the DIG trial had severe and more advanced disease as evidenced by the presence of NYHA III–IV symptoms, LVEF <25%, ...
In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...
Three independent pharmacokinetic studies were conducted to assess potential drug interactions between argatroban administered concomitantly with commonly prescribed drugs in the hospital setting that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback